findmyKOL

Mohamed Khayata, MD

Basic profile

Cleveland Clinic

ORCID↗NPI↗
✓ Full record
RegionCleveland, OH · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mohamed Khayata is a Cardiology physician affiliated with Cleveland Clinic. OpenAlex indexes 84 publications with 642 citations (h-index 15).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
84publications

Distinct works indexed by OpenAlex, matched via ORCID.

642citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

9500 Euclid Ave
Cleveland, OH 441953578

Telephone

164-442-2002

Provider last certified this registry record 1 Mar 2024.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    78.8%
    Beta blocker19.6%
    Metoprolol Succinate70%Metoprolol Tartrate16%Carvedilol15%
    Part D≥58 patients
    Statin15.5%
    Rosuvastatin Calcium50%Atorvastatin Calcium39%Pravastatin Sodium11%
    Part D<11 patients

    + 10 more classes in this area

  • Blood & clotting

    16.1%
    Factor Xa inhibitor13.1%
    Eliquis86%Xarelto14%
    Part D<11 patients
    P2Y12 inhibitor1.8%
    Clopidogrel100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    5.1%
    SGLT2 inhibitor5.1%
    Jardiance70%Farxiga30%
    Part D<11 patients
Where care is delivered (Part B)27.5% facility · 72.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”